Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Samarth Kulkarni Insider Profile
18 Followers
Samarth Kulkarni, CEO, Director at Crispr Therapeutics AG, holds 408.12K shares in Crispr Therapeutics AG (Ticker: CRSP), holds ― shares in Black Diamond Therapeutics (Ticker: BDTX), holds ― shares in Repare Therapeutics (Ticker: RPTX).
Samarth Kulkarni Crispr Therapeutics AG (CRSP)CEO, Director
Crispr Therapeutics AG (CRSP)
CEO, Director
Ranked #13,473 out of 98,624 Corporate Insiders
Profitable Transactions
4 out of 7 Profitable Transactions
Average Return
+18.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Samarth Kulkarni holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Dec 18, 2019 - Dec 18, 2020
Return:+127.20%
The most profitable trade made by Samarth Kulkarni
Samarth Kulkarni's Trading History
Crispr Therapeutics AG
Apr 17, 2024
CEO, Director
Uninformative Sell
1.17M
$21.96M
Black Diamond Therapeutics
―
Director
―
―
Repare Therapeutics
―
Director
―
―
Centessa Pharmaceuticals
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Samarth Kulkarni's performance on stock
You May Also Like
Samarth Kulkarni insider profile FAQ
What is the percentage of profitable transactions made by Samarth Kulkarni?
The percentage of profitable transactions made by Samarth Kulkarni is 57%.
What is the average return per transaction made by Samarth Kulkarni?
The average return per transaction made by Samarth Kulkarni is 18.10%.
What stocks does Samarth Kulkarni hold?
Samarth Kulkarni holds: CRSP, BDTX, RPTX, CNTA stocks.
What was Samarth Kulkarni’s latest transaction?
Samarth Kulkarni latest transaction was an Uninformative Sell of $1.17M.
What was Samarth Kulkarni's most profitable transaction?
Samarth Kulkarni’s most profitable transaction was an Informative Buy of CRSP stock on December 18, 2019. The return on the trade was 127.20%.
What is Samarth Kulkarni's role in Crispr Therapeutics AG?
Samarth Kulkarni's role in Crispr Therapeutics AG is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.